The Spectator Index on Nostr: BREAKING: The 🇺🇸 FDA has recommended Eli Lilly's Alzheimer's drug donanemab, ...
BREAKING: The 🇺🇸 FDA has recommended Eli Lilly's Alzheimer's drug donanemab, facilitating its full approval in the United States later this year.
Published at
2024-06-10 22:01:06Event JSON
{
"id": "8c5ed5df08c72f55c79e8f0eb1afcf764e556016004e28fdc2e42932fe98bc1c",
"pubkey": "ac813098dd803d0d0aee529f34b7db66c77659aa22bb53299cbfa3d92a1f7e82",
"created_at": 1718049666,
"kind": 1,
"tags": [
[
"proxy",
"https://hell.twtr.plus/objects/478d9783-361c-4576-b7f1-27868ee4f12f",
"activitypub"
]
],
"content": "BREAKING: The 🇺🇸 FDA has recommended Eli Lilly's Alzheimer's drug donanemab, facilitating its full approval in the United States later this year.",
"sig": "4134d7ee9dc9d57a3ddce2030610b638f954d29c11b2cb01203e27c351a3636d9d106348dc7a1493e9fc4dc0e5a8ae7b060abae1c690b83a407e48ae9356c4f5"
}
